REDWOOD CITY, Calif.--(BUSINESS WIRE)--EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced the launch of the TIF (Transoral Incisionless Fundoplication) Registry Study.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced the launch of the TIF (Transoral Incisionless Fundoplication) Registry Study.